Human immunodeficiency virus type 1 cell cycle control: Vpr is cytostatic and mediates G2 accumulation by a mechanism which differs from DNA damage checkpoint control

Journal of Virology

Volumn 70, Issue 4, 1996, Pages 2324-2331

  Bartz, Steven R ^a   Rogel, Mark E ^a   Emerman, Michael ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS PROTEIN;

ARTICLE; CELL CYCLE G2 PHASE; CYTOSTASIS; DNA DAMAGE; DNA DETERMINATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEUKEMIA CELL LINE; NONHUMAN; PRIORITY JOURNAL; VIRUS CELL INTERACTION;

EID: 0029993519     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.4.2324-2331.1996     Document Type: Article

References (42)

1. Agarwal, M., A. Agarwal, W. R. Taylor, and G. R. Stark. 1995. p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts. Proc Natl. Acad. Sci. USA 92:8493-8497.
2. Broek, D., R. Bartlett, K. Crawford, and P. Nurse. 1991. Involvement of p34cdc2 in establishing the dependency of S phase on mitosis Nature (London) 349:388-393.
3. Burns, J. C., T. Friedmann, W. Driever, M. Burrascano, and J. K. Yee. 1993. Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. Proc. Natl. Acad. Sci. USA 90:8033-8037.
4. Chen, G., L. Shi, D. W. Litchfield, and A. H. Greenberg. 1995. Rescue from granzyme B-induced apoptosis by Wee 1 kinase. J. Exp. Med. 181:2295-2300.
5. Cohen, E. A., E. F. Terwilliger, Y. Jalinoos, J. Proulx, J. G. Sodroski, and W. A. Haseltine. 1990. Identification of HIV-1 vpr product and function. J. Acquired Immune Defic Syndr 3:11-18.
6. Coleman, T. R., and W. G. Dunphy. 1994. Cdc2 regulatory factors Curr Opin. Cell Biol. 6:S77-882.
7. Finkel, T. H., G. Tudor-Williams, N. K. Banda, M. F. Cotton, T. Curiel, C. Monks, T. W. Baba, R. M. Ruprecht, and A. Kupper. 1995. Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes Nature Med. 1:129-134.
8. Friedrich, T. D., J. Laffin, and J. M. Lehman. 1992. Simian virus 40 large T-antigen function is required for induction of tetraploid DNA content during lytic infection. J. Virol. 66:4576-4579.
9. Gibbs, J. S., A. A. Lackner, S. M. Lang, M. A. Simon, P. K. Sehgal, M. D. Daniel, and R. C. Desrosiers. 1995. Progression to AIDS in the absence of a gene for vpr or vpr. J. Virol. 69:2378-2383.
10. Greenberg, A. H., and D. W. Litchfield. 1995. Granzymes and apoptosis. targeting the cell cycle. Curr. Top. Microbiol. Immunol. 198:95-119
11. Hayles, J., D. Fisher, A. Woollard, and P. Nurse. 1994. Temporal order of S phase and mitosis in fission yeast is determined by the state of the p34cdc2-mitotic B cyclin complex. Cell 78:813-822.
12. cdc2 activity. J Virol. 69:6705-6711.
13. Heinzinger, N., M. Bukrinsky, S. Haggerty, A. Ragland, V. KewalRamani, M. Lee, H. Gendelman, L. Ratner, M. Stevenson, and M. Emerman. 1994. The HIV-1 Vpr protein influences nuclear targetting of viral nucleic acids in non-dividing cells. Proc. Natl. Acad Sci. USA 91:7311-7315.
14. Ho, D. D., A. U. Neumann, A. S. Perelson, W. Chen, J. M. Leonard, and M. Markowitz. 1995 Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature (London) 373:123-126.
15. Hoch, J., S. M. Lang, M. Weeger, C. Stahl-Hennig, C. Coulibaly, U. Dittmer, G. Hunsmann, D. Fuchs, J. Müller, S. Sopper, B. Fleckenstein, and K. T. Überta. 1995. vpr deletion mutant of simian immunodeficiency virus induces AIDS in rhesus monkeys. J. Virol. 69:4807-4813.
16. 2 + M phase of the cell cycle J. Virol. 69:6304-6313.
17. Jung, J. U., M. Stager, and R. C. Desrosiers. 1994. Virus-encoded cyclin Mol. Cell. Biol. 14:7235-7244.
18. Kastan, M. B., Q. Zhan, W. S. el-Deiry, F. Carrier, T. Jacks, W. V. Walsh, B. S. Plunkett, B. Vogelstein, and A. J. Fornace, Jr. 1992. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxiatelangiectasia. Cell 71:587-597.
19. KewalRamani, V. N., C. S. Park, P. A. Gallombardo, and M. Emerman. Protein stability influences human immunodeficiency virus type 2 Vpr virion incorporation and cell cycle effect. Virology, in press.
20. Kimpton, J., and M. Emennan. 1992. Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated β-galactosidase gene J. Virol. 66: 2232-2239.
21. Lang, S. M., M. Weeger, C. Stahl-Hennig, C. Coulibaly, G. Hunsmann, J. Müller, H. Müller-Hermelink, D. Fuchs, H. Wachter, M. M. Daniel, R. C. Desrosiers, and B. Fleekenstein. 1993 Importance of vpr for infection of rhesus monkeys with simian immunodeficiency virus. J. Virol. 67:902-912.
22. gag precursor for incorporation of the Vpr product into human immunodeficiency virus type 1 viral particles. J. Virol 68:1926-1934.
23. Lehman, T. A., W. P. Bennett, R. A. Metcalf, J. A. Welsh, J. Ecker, R. V. Modali, S. Ullrich, J. W. Romano, E. Appella, J. R. Testa, et al. 1991 p53 mutations, ras mutations, and p53-heat shock 70 protein complexes in human lung carcinoma cell lines. Cancer Res. 51:4090-4096.
24. Levy, D. N., L. S. Fernandes, W. V. Williams, and D. B. Weiner. 1993. Induction of cell differentiation by human immunodeficiency virus 1 vpr Cell 72:545-550.
25. Lu, Y. L., P. Spearman, and L. Ratner. 1993. Human immunodeficiency virus type 1 viral protein R localization in infected cells and virions J Virol 67:6542-6550.
26. Ludlaw, J. W. 1993. Interactions between SV40 large-tumor antigen and the growth suppressor proteins pRB and p53. FASEB J. 7:866-871.
27. Miller, A. D., and G. J. Roseman. 1989. Improved retrovirus vectors for gene transfer and expression. BioTechniques 7:980.
28. Moran, E. 1993. Interaction of adenoviral proteins with pRB and p53. FASEB J 7:880-885.
29. Ogawa, K., R. Shibata, T. Kiyomasu, I. Higuchi, Y. Kishida, A. Ishimoto, and A. Adachi. 1989. Mutational analysis of the human immunodeficiency virus vpr open reading frame J. Virol. 63:4110-4114.
30. Paxton, W., R. I. Connor, and N. R. Landau. 1993. Incorporation of Vpr into human immunodeficiency virus type 1 virions: requirement for the p6 region of gag and mutational analysis. J. Virol. 67:7229-7237.
31. Peden, K., M. Emerman, and L. Montagnier. 1991 Changes in growth properties on passage in tissue culture of viruses derived from infectious molecular clones of HIV-1LAI, HIV-1MAL, and HIV-1ELI. Virology 185: 661-672
32. Planelles, V., F. Bachelerie, J. B. M. Jowett, A. Haislip, Y. Xie, B. Peyman, T. Masuda, and I. S. Y. Chen. 1995. Fate of the human immunodeficiency virus type 1 provirus in infected cells: a role for vpr. J Virol 69:5883-5889.
33. cdc2-cyclin B. J. Virol 69:6859-6864.
34. Rogel, M. E., L. I. Wu, and M. Emerman. 1995. The human immunodeficiency virus type 1 vpr gene prevents cell proliferation during chronic infection J Virol. 69:882-888.
35. Russell, K. J., L. W. Wiens, G. W. Demers, D. A. Galloway, S. E. Plon, and M. Groudine. 1995. Abrogation of the G2 checkpoint results in differential radiosensitization of G1 checkpoint-deficient and G1 checkpoint-competent cells. Cancer Res 55:1639-1642.
36. Scarano, F. J., J. A. Laffin, J. M. Lehman, and T. D. Friedrich. 1994. Simian virus 40 prevents activation of M-phase-promoting factor during lytic infection. J Virol. 68:2355-2361.
37. Sodroski, J., W. C. Goh, C. Rosen, K. Campbell, and W. A. Haseltine. 1986. Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity. Nature (London) 322:470-474.
38. Tristem, M., C. Marshall, A. Karpas, and F. Hill. 1992 Evolution of the primate lentiviruses: evidence from vpx and vpr. EMBO J. 11:3405-3412.
39. Usui, T., M. Yoshida, K. Abe, H. Osada, K. Isono, and T. Beppu. 1991. Uncoupled cell cycle without mitosis induced by a protein kinase inhibitor, K-252a. J. Cell Biol. 115:1275-1282.
40. Vousden, K. 1993. Interactions of human papillomavirus transforming proteins with the products of tumor suppressor genes. FASEB J. 7:872-879.
41. Wei, X., S. K. Ghosh, M. E. Taylor, V. A. Johnson, E. A. Emini, P. Deutsch, J. D. Lifson, S. Bohoeffer, M. A. Nowak, B. H. Hahn, M. S. Saag, and G. M. Shaw. 1995. Viral dynamics in human immunodeficiency virus type 1 infection. Nature (London) 373:117-122.
42. Yee, J. K., A. Miyanohara, P. LaPorte, K. Bouic, J. C. Burns, and T. Friedmann. 1994 A general method for the generation of high-titer. pantropic retroviral vectors: highly efficient infection of primary hepatocytes. Proc. Natl. Acad. Sci. USA 91:9564-9568.